Development of a diagnostic test using Multiplex In Solution Protein Array (MISPA) for distinguishing COVID-19 infection from other viral infections

Medicine & Life Sciences

1. Protein Array Analysis 100%
2. Routine Diagnostic Tests 74%
3. India 63%
4. Virus Diseases 58%
5. Technology 51%
6. SARS Virus 42%
7. Financial Management 41%
8. Infections 37%
9. Names 34%
10. Organized Financing 33%
11. Organizations 30%
12. Viruses 28%
13. Antibody Formation 25%
14. Squamous Cell Carcinoma 24%
15. Antigens 18%
16. Clone Cells 17%
17. Human Influenza 13%
18. Proteins 13%
19. Disease Outbreaks 12%
20. Patient Identification Systems 10%
21. Serum 9%
22. Financial Support 9%
23. Bioengineering 9%
24. Coronavirus 9%
25. Proof of Concept Study 8%
26. Viral Antigens 8%
27. Signal-To-Noise Ratio 8%
28. Antibodies 7%
29. Birds 7%
30. Pandemics 7%
31. Proteome 7%
32. Feasibility Studies 7%
33. Nucleic Acids 7%
34. High-Throughput Nucleotide Sequencing 6%
35. Early Detection of Cancer 6%
36. Respiratory System 6%
37. Respiratory Insufficiency 6%
38. Noise 6%
39. Libraries 6%
40. Pneumonia 5%
41. Economics 5%
42. Research Personnel 5%